Drugs / Diphencyprone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05481658 | Oct 2022 → Dec 2029 expected | — | Nicholas Gulati | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphencyprone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05481658 ↗ |
| Known as | DPCP | “Diphencyprone (DPCP)” NCT05481658 ↗ |
| Route | Topical | “administered topically twice weekly for 12 weeks” NCT05481658 ↗ |